Insiders / Duncan Barbara Gayle
Duncan Barbara Gayle
CIK 1353128personinsider
Companies
3
First seen
Mar 2, 2026
Last activity
Jun 23, 2026
Companies
| Company | Shares held | Latest |
|---|---|---|
| Atea Pharmaceuticals, Inc. · AVIR | 92,350 | — |
| Halozyme Therapeutics Inc · HALO | 23,715 | — |
| Ovid Therapeutics Inc. · OVID | — | — |
All securities held
6 positions · latest reported per filing
| Company | Security | Shares |
|---|---|---|
| Atea Pharmaceuticals, Inc. | Common Stock | 92,350 |
| Atea Pharmaceuticals, Inc. | Stock Option (Right to Buy)Derivative | 37,700 |
| Atea Pharmaceuticals, Inc. | Restricted Stock UnitsDerivative | 26,700 |
| Halozyme Therapeutics Inc | Common Stock | 23,715 |
| Halozyme Therapeutics Inc | Option to Purchase Common StockDerivative | 6,040 |
| Ovid Therapeutics Inc. | Employee Stock Option (Right to Buy)Derivative | 65,000 |
Activity
InsidersInstitutions
This person's insider trades (Form 4), across every company.| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Jun 18, 2026 | Exercise | AVIR Atea Pharmaceuticals, Inc. Common Stock | $0 | +30K +47.17% | 92,350 0.12% of shares | low |
| May 5, 2026 | Grant | HALO Halozyme Therapeutics Inc Common Stock | $0 | +4K +19.06% | 23,715 0.02% of shares | low |
| Jun 18, 2026 | Grant | AVIR Atea Pharmaceuticals, Inc. Stock Option (Right to Buy) | — | +38K | 37,700 0.05% of shares | low |
| Jun 18, 2026 | Grant | AVIR Atea Pharmaceuticals, Inc. Restricted Stock Units | — | +27K | 26,700 0.03% of shares | low |
| Jun 18, 2026 | Exercise | AVIR Atea Pharmaceuticals, Inc. Restricted Stock Units | — | -30K -100.00% | 0 0.00% of shares | low |
| May 5, 2026 | Grant | HALO Halozyme Therapeutics Inc Option to Purchase Common Stock | — | +6K | 6,040 <0.01% of shares | low |
| Feb 26, 2026 | Grant | OVID Ovid Therapeutics Inc. Employee Stock Option (Right to Buy) | — | +65K | 65,000 0.03% of shares | low |